References
- Bertoni J. Metrizamide inhibits human brain hexokinase. Neurology 1982; 32: 884
- Brooks B. S., Gammal T. E., van Tasel P., Stevenson T. C. C1-C2 myelography with iohexol and metrizamide. AJNR 1985; 6: 935
- Butler M., Cornell S., Damasio A. Aphasia following pluridirectional tomography with metrizamide. Arch. Neurol. 1985; 42: 39
- Ekholm S., Reece K., Coleman J., Kido D., Fischer H. Metrizamide, potential in vivo inhibitor of glucose metabolism. Radiology 1983; 147: 119
- Ekholm S., Reece K., Foley M., Kido D., Morris T. The effect of iohexol on glucose metabolism compared with metrizamide. Invest. Radiol. 1984; 19: 574
- Gerbarski S. G., Gabrielsen T. G., Karke J. E., Latack J. T., Yang P. J., Hoff J. T. Iohexol versus metrizamide for cervical myelography. AJNR 1985; 6: 923
- Lundervold A., Sortland O. EEG disturbances following myelography, cisternography and ventriculography with metrizamide. Acta Radiol. Suppl. 1977; 355: 379
- Macpherson P., Teasdale E., McGeorge A. P. Direct puncture versus runup cervical myelography with iopamidol. A comparison of side effects, EEG changes and radiographic quality. J. Neurol. Neurosurg. Psychiatry 1983; 46: 959
- Nakstad P., Helgetveit A., Aaserud O., Ganes T., Nyberg-Hansen R. Iohexol compared to metrizamide in cervical and thoracic myelography. Neuroradiology 1983; 26: 479
- Simon J., Ekholm S., Morris T., Isaac L., Tayrien M. The effect of subarachnoid metrizamide and iohexol on cerebral glucose metabolism in vivo. Acta Radiol. Suppl. 1986; 369: 549
- Smirniotopoulos J., Murphy F., Schellinger D., Kurtzke J., Vorts F. Cortical blindness after metrizamide myelography. Arch. Neurol. 1984; 41: 224